Abiomed Says Class Action Lawsuit Without Merit; Intends to Defend Vigorously
Posted on November 16, 2012 at 18:53 PM EST
Abiomed (NASDAQ: ABMD ) today announced that a purported class action complaint was filed on November 16, 2012 in the United States District Court for the District of Massachusetts by Karse Simon and Arlene Simon, on behalf of themselves and persons or entities that purchased or acquired Abiomed's securities